Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | -2.32 | -0.28 | 0.06 |
| FCF Yield | 10.20% | 3.31% | -1.07% | 16.55% |
| EV / EBITDA | 6.43 | 5.53 | 7.67 | 4.71 |
| Quality | ||||
| ROIC | 15.68% | 9.94% | 12.83% | 37.58% |
| Gross Margin | 38.14% | 36.98% | 40.56% | 53.67% |
| Cash Conversion Ratio | 1.09 | 0.74 | 0.24 | 1.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.63% | -7.59% | 10.72% | 32.89% |
| Free Cash Flow Growth | 517.27% | 317.50% | -104.99% | 165.18% |
| Safety | ||||
| Net Debt / EBITDA | 0.14 | 0.39 | 0.41 | -0.01 |
| Interest Coverage | 7.12 | 5.21 | 6.78 | 23.08 |
| Efficiency | ||||
| Inventory Turnover | 11.14 | 6.93 | 8.07 | 10.87 |
| Cash Conversion Cycle | 59.11 | 75.11 | 39.51 | 12.74 |